tradingkey.logo
tradingkey.logo
Search

Crinetics Pharmaceuticals Inc

CRNX
Add to Watchlist
83.865USD
+0.135+0.16%
Close 07-27 16:00ETQuotes delayed by 15 min
8.83BMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
12.06%
Wellington Management Company, LLP
7.62%
BlackRock Institutional Trust Company, N.A.
6.58%
Farallon Capital Management, L.L.C.
6.58%
Driehaus Capital Management, LLC
6.06%
Other
61.10%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
12.06%
Wellington Management Company, LLP
7.62%
BlackRock Institutional Trust Company, N.A.
6.58%
Farallon Capital Management, L.L.C.
6.58%
Driehaus Capital Management, LLC
6.06%
Other
61.10%
Shareholder Types
Shareholders
Proportion
Investment Advisor
49.95%
Investment Advisor/Hedge Fund
40.84%
Hedge Fund
14.42%
Venture Capital
1.76%
Research Firm
1.71%
Individual Investor
1.57%
Private Equity
0.95%
Bank and Trust
0.58%
Pension Fund
0.40%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
556
115.89M
109.92%
-3.16M
2025Q4
525
110.25M
122.53%
+10.44K
2025Q3
543
110.25M
126.46%
+2.35M
2025Q2
527
106.83M
124.47%
+1.78M
2025Q1
508
105.21M
122.53%
-8.81M
2024Q4
492
102.43M
107.05%
+15.47M
2024Q3
460
87.33M
121.15%
+1.87M
2024Q2
441
84.74M
119.85%
+1.98M
2024Q1
399
82.75M
110.72%
-4.21M
2023Q4
366
73.18M
119.64%
+1.80M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
12.71M
12.14%
+175.28K
+1.40%
Dec 31, 2025
Wellington Management Company, LLP
8.04M
7.68%
-344.10K
-4.11%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
6.94M
6.63%
+290.48K
+4.37%
Dec 31, 2025
Farallon Capital Management, L.L.C.
6.93M
6.62%
+1.16M
+20.16%
Dec 31, 2025
Driehaus Capital Management, LLC
6.39M
6.1%
-93.87K
-1.45%
Dec 31, 2025
T. Rowe Price Associates, Inc.
5.12M
4.89%
-84.32K
-1.62%
Dec 31, 2025
Janus Henderson Investors
4.44M
4.24%
+581.90K
+15.08%
Dec 31, 2025
EcoR1 Capital, LLC
4.29M
4.1%
--
--
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Pharmaceuticals ETF
3.24%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.92%
Tema Heart & Health ETF
1.9%
ALPS Medical Breakthroughs ETF
1.79%
iShares U.S. Pharmaceuticals ETF
1.51%
First Trust Multi-Manager Small Cap Opportunities ETF
1.31%
Virtus LifeSci Biotech Clinical Trials ETF
0.92%
ProShares Ultra Nasdaq Biotechnology
0.52%
Invesco Nasdaq Biotechnology ETF
0.4%
iShares Biotechnology ETF
0.34%
View more
State Street SPDR S&P Pharmaceuticals ETF
Proportion3.24%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion2.92%
Tema Heart & Health ETF
Proportion1.9%
ALPS Medical Breakthroughs ETF
Proportion1.79%
iShares U.S. Pharmaceuticals ETF
Proportion1.51%
First Trust Multi-Manager Small Cap Opportunities ETF
Proportion1.31%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.92%
ProShares Ultra Nasdaq Biotechnology
Proportion0.52%
Invesco Nasdaq Biotechnology ETF
Proportion0.4%
iShares Biotechnology ETF
Proportion0.34%
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.